• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antithrombotic regimens in patients with atrial fibrillation and coronary disease: optimizing efficacy and safety.

作者信息

Markowitz Steven M

出版信息

J Am Coll Cardiol. 2013 Sep 10;62(11):990-1. doi: 10.1016/j.jacc.2013.04.072. Epub 2013 Jun 7.

DOI:10.1016/j.jacc.2013.04.072
PMID:23747772
Abstract
摘要

相似文献

1
Antithrombotic regimens in patients with atrial fibrillation and coronary disease: optimizing efficacy and safety.心房颤动合并冠心病患者的抗栓治疗方案：优化疗效与安全性
J Am Coll Cardiol. 2013 Sep 10;62(11):990-1. doi: 10.1016/j.jacc.2013.04.072. Epub 2013 Jun 7.
2
A persisting dilemma for triple antithrombotic therapy: are we close to finding the correct answer?三联抗栓治疗中持续存在的困境：我们距离找到正确答案还有多远？
J Am Coll Cardiol. 2014 Jul 15;64(2):231. doi: 10.1016/j.jacc.2013.10.089. Epub 2014 Feb 5.
3
Reply: A persisting dilemma for triple antithrombotic therapy: are we close to finding the correct answer?回复：三联抗栓治疗中一个持续存在的困境：我们是否即将找到正确答案？
J Am Coll Cardiol. 2014 Jul 15;64(2):231-2. doi: 10.1016/j.jacc.2013.11.049. Epub 2014 Feb 5.
4
Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.心肌梗死后和冠状动脉介入治疗后的心房颤动患者的口服抗凝和抗血小板治疗。
J Am Coll Cardiol. 2013 Sep 10;62(11):981-9. doi: 10.1016/j.jacc.2013.05.029. Epub 2013 Jun 7.
5
Optimal antithrombotic treatment in patients with atrial fibrillation and coronary stents: an update.心房颤动合并冠状动脉支架置入患者的最佳抗栓治疗：最新进展
Curr Opin Cardiol. 2016 Jul;31(4):356-65. doi: 10.1097/HCO.0000000000000306.
6
Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.房颤合并冠状动脉疾病患者的三联与双联抗栓治疗
Am J Med. 2016 Jun;129(6):592-599.e1. doi: 10.1016/j.amjmed.2015.12.026. Epub 2016 Jan 18.
7
Antithrombotic strategies for preventing long-term major adverse cardiovascular events in patients with non-valvular atrial fibrillation who undergo percutaneous coronary intervention.接受经皮冠状动脉介入治疗的非瓣膜性心房颤动患者预防长期主要不良心血管事件的抗栓策略。
Expert Opin Pharmacother. 2017 Jun;18(9):875-883. doi: 10.1080/14656566.2017.1329822. Epub 2017 May 22.
8
Triple therapy for atrial fibrillation and percutaneous coronary intervention.用于心房颤动和经皮冠状动脉介入治疗的三联疗法。
Curr Opin Cardiol. 2015 Nov;30(6):690-6. doi: 10.1097/HCO.0000000000000228.
9
Management of antiplatelet and anticoagulant therapy in patients with atrial fibrillation in the setting of acute coronary syndromes or percutaneous coronary interventions.急性冠状动脉综合征或经皮冠状动脉介入治疗背景下房颤患者抗血小板和抗凝治疗的管理
Circ Cardiovasc Interv. 2014 Feb;7(1):113-24. doi: 10.1161/CIRCINTERVENTIONS.113.001150.
10
Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update.接受经皮冠状动脉介入治疗的心房颤动患者的抗栓治疗：北美视角 - 2016年更新
Circ Cardiovasc Interv. 2016 Nov;9(11). doi: 10.1161/CIRCINTERVENTIONS.116.004395.